Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Coating Systems & Additives
Direct Compression
Disintegrants & Superdisintegrants
Lubricants & Glidants
Controlled & Modified Release
Thickeners and Stabilizers
Granulation
Co-Processed Excipients
Solubilizers
Film Formers & Plasticizers
Parenteral
Emulsifying Agents
Taste Masking
Chewable & Orodispersible Aids
API Stability Enhancers
Coloring Agents
Topical
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Stivarga manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stivarga, including repackagers and relabelers. The FDA regulates Stivarga manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stivarga API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Stivarga manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Stivarga supplier is an individual or a company that provides Stivarga active pharmaceutical ingredient (API) or Stivarga finished formulations upon request. The Stivarga suppliers may include Stivarga API manufacturers, exporters, distributors and traders.
click here to find a list of Stivarga suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Stivarga DMF (Drug Master File) is a document detailing the whole manufacturing process of Stivarga active pharmaceutical ingredient (API) in detail. Different forms of Stivarga DMFs exist exist since differing nations have different regulations, such as Stivarga USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Stivarga DMF submitted to regulatory agencies in the US is known as a USDMF. Stivarga USDMF includes data on Stivarga's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stivarga USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Stivarga suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Stivarga Drug Master File in Korea (Stivarga KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Stivarga. The MFDS reviews the Stivarga KDMF as part of the drug registration process and uses the information provided in the Stivarga KDMF to evaluate the safety and efficacy of the drug.
After submitting a Stivarga KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Stivarga API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Stivarga suppliers with KDMF on PharmaCompass.
A Stivarga written confirmation (Stivarga WC) is an official document issued by a regulatory agency to a Stivarga manufacturer, verifying that the manufacturing facility of a Stivarga active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Stivarga APIs or Stivarga finished pharmaceutical products to another nation, regulatory agencies frequently require a Stivarga WC (written confirmation) as part of the regulatory process.
click here to find a list of Stivarga suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stivarga as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Stivarga API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Stivarga as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Stivarga and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stivarga NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Stivarga suppliers with NDC on PharmaCompass.
Stivarga Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Stivarga GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Stivarga GMP manufacturer or Stivarga GMP API supplier for your needs.
A Stivarga CoA (Certificate of Analysis) is a formal document that attests to Stivarga's compliance with Stivarga specifications and serves as a tool for batch-level quality control.
Stivarga CoA mostly includes findings from lab analyses of a specific batch. For each Stivarga CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Stivarga may be tested according to a variety of international standards, such as European Pharmacopoeia (Stivarga EP), Stivarga JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stivarga USP).
LOOKING FOR A SUPPLIER?
